Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

US Oral Solid Dosage CDMO Top Companies and Strategic Involvements

Date : 07 July 2026

Top Companies and Their Offerings

U.S. Oral Solid Dosage CDMO Market Companies are Catalent, Inc., Aenova Group, Lonza Group AG, Cambrex Corporation, Thermo Fisher Scientific Inc., Piramal Pharma Solutions, Recipharm AB

What are the Recent Developments in the Market?

  • In March 2026, an independent, operator-owned contract development and manufacturing organization (CDMO) was launched by Forma Life Sciences. The organization will offer services such as oral solid dosage formulation development, commercial drug product manufacturing, and clinical manufacturing across the U.S.
  • In February 2026, the rebirth of a stand-alone contract development and manufacturing organization (CDMO) was marked by Halo Pharma by resuming operations of two manufacturing facilities operating under Noramco. Halo Pharma aims to provide capabilities across multiple dosage forms, including solid, liquid, and semi-solid formulations.

Market Ecosystem Analysis

Ecosystem Category Key Participants Explanation
Technology Providers GEA Group, Syntegon, IMA Group, Glatt, Fette Compacting Supply tablet presses, coating systems, granulation and continuous manufacturing technologies.
Product Manufacturers Catalent, Thermo Fisher Scientific (Patheon), Lonza, Recipharm, Piramal Pharma Solutions Manufacture commercial oral solid dosage products for pharmaceutical clients.
Service Providers Alcami, Metrics Contract Services, Bora Pharmaceuticals, Adare Pharma Solutions, PCI Pharma Services Offer formulation development, analytical testing, manufacturing, packaging and commercialization.
Platform Providers Catalent OptiForm®, Lonza Capsules & Health Ingredients, Adare DiffCORE®, Thermo Fisher Oral Technologies Proprietary formulation and drug delivery platforms.
CROs/CDMOs Catalent, Thermo Fisher (Patheon), Lonza, Piramal Pharma Solutions, Alcami, Adare Pharma Solutions, PCI Pharma Services, Metrics Contract Services Provide integrated development and commercial manufacturing services.
Software Vendors Körber Pharma, Siemens Digital Industries, SAP, Emerson, Werum PAS-X Manufacturing execution systems (MES), digital manufacturing, quality management and serialization.
Research Institutions University of Michigan, Purdue University, Rutgers University, University of Wisconsin–Madison, National Institute for Pharmaceutical Technology and Education (NIPTE) Support pharmaceutical formulation research and manufacturing innovation.
End-User Industries Pharmaceutical, Biotechnology, Generic Pharmaceuticals, Specialty Pharmaceuticals Primary customers outsourcing oral dosage manufacturing.

Market Value Chain Analysis

R&D

  • The R&D of the U.S. oral solid dosage CDMO focuses on enhancing spray-dried dispersions and manufacturing workflows.
  • Key players: Catalent, Inc., Lonza Group AG, Thermo Fisher Scientific Inc.

Packaging and Serialization

  • The packaging and serialization of U.S. oral solid dosage CDMO involves the use of automated high-speed bottling and blister lines integrated with advanced serialization software.
  • Key players: Catalent, Inc., Piramal Pharma Solutions, Thermo Fisher Scientific Inc.

Patient Support and Services

  • Patient support and services by the U.S. oral solid dosage CDMO are provided by developing customized, high-compliance drug formats and calendarized blister packs.
  • Key players: Catalent, Inc., Thermo Fisher Scientific Inc.
Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Catalent Somerset, New Jersey USA One of the world's largest pharmaceutical CDMOs with extensive US oral solid manufacturing network Oral solid dosage development, formulation, clinical and commercial tablet/capsule manufacturing
Thermo Fisher Scientific (Patheon) Waltham, Massachusetts USA Global CDMO leader with major US oral solid manufacturing operations OSD development, commercial manufacturing, packaging, analytical services
Lonza Basel Switzerland Major global CDMO with oral dosage development and manufacturing capabilities serving US clients Oral dosage formulation, capsules, commercial manufacturing
Piramal Pharma Solutions Mumbai, Maharashtra India Significant US manufacturing footprint with strong oral solid dosage services API integration, formulation development, tablets, capsules, commercial production
Recipharm Stockholm Sweden Global CDMO operating US facilities with established oral solid dosage manufacturing capabilities Oral solid manufacturing, formulation, packaging, lifecycle management
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Adare Pharma Solutions Lawrenceville, New Jersey USA Leading specialist in oral drug delivery technologies and commercial manufacturing Modified-release tablets, taste masking, oral formulations
PCI Pharma Services Philadelphia, Pennsylvania USA Strong commercial manufacturing and packaging capabilities for oral solid products OSD manufacturing, packaging, clinical supply
Bora Pharmaceuticals Taipei Taiwan Expanded US CDMO presence through acquisitions and oral dosage manufacturing Tablets, capsules, commercial manufacturing
Alcami Corporation Wilmington, North Carolina USA Provides formulation development and commercial oral solid manufacturing Formulation development, analytical testing, tablet manufacturing
Quotient Sciences Nottingham United Kingdom Integrated development and manufacturing with US operations supporting OSD products Drug development, formulation, clinical manufacturing
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Metrics Contract Services Greenville, North Carolina USA Specialized oral solid dosage CDMO focused on formulation development and manufacturing Tablets, capsules, modified-release formulations
CoreRx Clearwater, Florida USA Specialized pharmaceutical development and manufacturing company Clinical OSD manufacturing, formulation development
Mayne Pharma Salisbury South, South Australia Australia Operates US manufacturing supporting oral solid pharmaceuticals Generic oral solid manufacturing, formulation
Societal CDMO Gainesville, Georgia USA Focused CDMO with expertise in oral solid dosage and specialty pharmaceuticals Drug development, commercial manufacturing
AustinPx Georgetown, Texas USA Fast-growing formulation and manufacturing specialist emphasizing complex oral dosage forms Bioavailability enhancement, spray drying, oral formulations

Market Growth

The U.S. oral solid dosage CDMO market size is calculated at USD 14.38 billion in 2025 continues to grow USD 15.33 Bn in 2026 due to the rising demand for specialized manufacturing technologies, generic drugs, and personalized medicine. It is expected to reach USD 27.2 billion by 2035, registering a CAGR of 6.58%

U.S. Oral Solid Dosage CDMO Market Size is USD 15.33 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales